IKNA - Ikena Oncology - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $3.71. This is a potential upside of $2.28 (159.44%) from yesterday's end of day stock price of $1.43.

Ikena Oncology's activity chart (see below) currently has 4 price targets and 2 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 151 days.

Highest price target for IKNA is $23, Lowest price target is $23, average price target is $23.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 25-Jul-2025. First documented stock forecast 13-Aug-2021.

Best performing analysts who are covering IKNA - Ikena Oncology:

Evan Seigerman Robert Burns Judah Frommer David Nierengarten

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$23

$21.57 (1508.39%)

$2

2 months 12 days ago
(25-Jul-2025)

0/3 (0%)

$21.57 (1508.39%)

Buy

$13

$11.57 (809.09%)

$13

2 years 4 months 21 days ago
(16-May-2023)

0/2 (0%)

$6.84 (111.04%)

Buy

$13

$-4.16 (-24.24%)

$27

2 years 6 months 22 days ago
(15-Mar-2023)

2/2 (100%)

$-38 (-74.51%)

604

Buy

$26

2 years 10 months 8 days ago
(29-Nov-2022)

0/2 (0%)

$18.7 (256.16%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IKNA (Ikena Oncology) average time for price targets to be met?

On average it took 151 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on IKNA (Ikena Oncology) with a proven track record?

EVAN SEIGERMAN

Which analyst has the current lower performing score on IKNA (Ikena Oncology) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on IKNA (Ikena Oncology)?

Evan Seigerman works at BMO and has 26 price targets and 14 ratings on IKNA

Which analyst is the currently most bullish on IKNA (Ikena Oncology)?

David Nierengarten with highest potential upside - $21.57

Which analyst is the currently most reserved on IKNA (Ikena Oncology)?

Evan Seigerman with lowest potential downside - -$4.16

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?